ECHO Renewal for the CANOE Study Cohort

CANOE 研究队列的 ECHO 更新

基本信息

  • 批准号:
    10745082
  • 负责人:
  • 金额:
    $ 132.05万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2023
  • 资助国家:
    美国
  • 起止时间:
    2023-09-01 至 2025-05-31
  • 项目状态:
    未结题

项目摘要

ABSTRACT The overarching goals of this application are to: 1) maintain retention of children in the Vanderbilt CANOE birth cohort with emphasis on diversity and implementation of the ECHO Cohort Protocol with high fidelity and conduct new enrollment, and 2) address key questions in the field about one of the most common and modifiable early life environmental exposures consistently associated with significantly increased asthma risk, respiratory syncytial virus (RSV) infection, delineating the severity-dependent and age-dependent effects of RSV infection on asthma risk. This innovative project has significant public health impact, as establishing the age- and severity-dependent relationship between RSV and asthma is the first and most important step in disease primary prevention. We propose to address key unanswered questions in the field: the severity- and age-dependent association of RSV and asthma, and the impact of infection on lung function. In addition, we will explore the broad impact of the SARS-CoV-2 pandemic on asthma incidence and control in an exploratory aim, which may provide support for multi-faceted environmental modifications in asthma prevention and control, and data to inform the potential impact of broad public health interventions. The birth cohort that this application supports is the Vanderbilt CANOE (Childhood Allergy and the NeOnatal Environment) study. CANOE is a birth cohort designed to identify and understand how environmental factors modify the development of the airway epithelium. The study includes the unique longitudinal sampling of the child airway throughout the first year of life, and annually. The Vanderbilt CANOE study has unique early life exposure and outcomes ascertainment, including surveillance for RSV and a novel biospecimen repository of nasal airway epithelial cells. The CANOE cohort also has important information for longitudinal development of the airway microbiome and the airway epithelium. The proposed research is innovative and timely given the anticipated licensure of multiple RSV prevention products in the coming year (maternal vaccines and long- acting monoclonal antibodies for infants). The proposed work represents a novel, multi-faceted approach to identifying and understanding the influence of severity of RSV infection and age of RSV infection on asthma risk and lung function. The answers to these questions will be critical to developing prevention strategies and informing public health expectations for RSV non-pharmaceutical preventive strategies and evaluating potential long-term value-added benefits of vaccines in preventing lifelong chronic respiratory disease. These data may not only bolster RSV vaccine acceptability and uptake in the US, but will almost certainly be useful in evaluating the cost-effectiveness of RSV prevention strategies in low and middle income countries.
摘要 该应用程序的首要目标是:1)保持范德比尔特CANOE分娩中的儿童保留 队列,重点是多样性和高保真的ECHO队列方案的实施, 进行新的登记,和2)解决该领域的关键问题,其中一个最常见的, 可改变的早期生活环境暴露与哮喘风险显著增加相关, 呼吸道合胞病毒(RSV)感染,描述了严重程度依赖性和年龄依赖性的影响, 呼吸道合胞病毒感染与哮喘风险这一创新项目具有重大的公共卫生影响,因为建立了 RSV和哮喘之间的年龄和严重程度依赖性关系是第一步,也是最重要的一步, 疾病一级预防。我们建议解决该领域尚未回答的关键问题: RSV和哮喘的年龄依赖性关联,以及感染对肺功能的影响。另外我们 将探索SARS-CoV-2大流行对哮喘发病率和控制的广泛影响, 目的,这可能为哮喘预防中的多方面环境改造提供支持, 控制和数据,以告知广泛的公共卫生干预措施的潜在影响。 此应用程序支持的出生队列是范德比尔特CANOE(儿童过敏和新生儿 环境)研究。CANOE是一个出生队列,旨在识别和了解环境因素 改变气道上皮的发育。这项研究包括独特的纵向抽样的 儿童气道在整个生命的第一年,每年。范德比尔特坎诺研究有独特的早期生活 暴露和结局确定,包括RSV监测和新的生物标本储存库, 鼻气道上皮细胞CANOE队列也有纵向发展的重要信息, 气道微生物组和气道上皮。建议的研究是创新和及时的,因为 预计明年将获得多种RSV预防产品的许可(孕产妇疫苗和长期 用于婴儿的单克隆抗体)。拟议的工作代表了一种新颖的,多方面的方法, 识别和了解RSV感染的严重程度和RSV感染的年龄对哮喘的影响 风险和肺功能。这些问题的答案对于制定预防战略至关重要, 告知公众对RSV非药物预防策略的期望,并评估潜在的 疫苗在预防终身慢性呼吸道疾病方面的长期增值效益。这些数据可以 不仅支持RSV疫苗在美国的可接受性和吸收, 评估中低收入国家RSV预防策略的成本效益。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Tina V Hartert其他文献

Tina V Hartert的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Tina V Hartert', 18)}}的其他基金

Identifying Asthma-causing RSV Strains and Elucidating the Mechanisms of RSV-mediated Asthma Development
鉴定引起哮喘的 RSV 菌株并阐明 RSV 介导的哮喘发展机制
  • 批准号:
    10230392
  • 财政年份:
    2020
  • 资助金额:
    $ 132.05万
  • 项目类别:
Identifying Asthma-causing RSV Strains and Elucidating the Mechanisms of RSV-mediated Asthma Development
鉴定引起哮喘的 RSV 菌株并阐明 RSV 介导的哮喘发展机制
  • 批准号:
    10301922
  • 财政年份:
    2020
  • 资助金额:
    $ 132.05万
  • 项目类别:
Newborn Metabolic Screening for Prediction of Childhood Respiratory Phenotypes
新生儿代谢筛查用于预测儿童呼吸表型
  • 批准号:
    9090671
  • 财政年份:
    2016
  • 资助金额:
    $ 132.05万
  • 项目类别:
Newborn Metabolic Screening for Prediction of Childhood Respiratory Phenotypes
新生儿代谢筛查用于预测儿童呼吸表型
  • 批准号:
    9250797
  • 财政年份:
    2016
  • 资助金额:
    $ 132.05万
  • 项目类别:
Clinical Ascertainment, Biospecimen Acquisition, Data Management and Analysis Research Core
临床确定、生物样本采集、数据管理和分析研究核心
  • 批准号:
    10460524
  • 财政年份:
    2011
  • 资助金额:
    $ 132.05万
  • 项目类别:
Identifying Asthma-causing RSV Strains and Elucidating the Mechanisms of RSV-mediated Asthma Development
鉴定引起哮喘的 RSV 菌株并阐明 RSV 介导的哮喘发展机制
  • 批准号:
    9975086
  • 财政年份:
    2011
  • 资助金额:
    $ 132.05万
  • 项目类别:
Clinical Ascertainment, Biospecimen Acquisition, Data Management and Analysis Research Core
临床确定、生物样本采集、数据管理和分析研究核心
  • 批准号:
    10262868
  • 财政年份:
    2011
  • 资助金额:
    $ 132.05万
  • 项目类别:
RSV to Asthma Cooperative Clinical Ascertainment and Biospecimen Research Core
RSV 与哮喘合作临床确定和生物样本研究核心
  • 批准号:
    8196536
  • 财政年份:
    2011
  • 资助金额:
    $ 132.05万
  • 项目类别:
Clinical Ascertainment, Biospecimen Acquisition, Data Management and Analysis Research Core
临床确定、生物样本采集、数据管理和分析研究核心
  • 批准号:
    10675721
  • 财政年份:
    2011
  • 资助金额:
    $ 132.05万
  • 项目类别:
RSV and asthma: Defining host and exposure variation on disease development
RSV 和哮喘:定义疾病发展的宿主和暴露变异
  • 批准号:
    10460527
  • 财政年份:
    2011
  • 资助金额:
    $ 132.05万
  • 项目类别:

相似海外基金

Rational design of rapidly translatable, highly antigenic and novel recombinant immunogens to address deficiencies of current snakebite treatments
合理设计可快速翻译、高抗原性和新型重组免疫原,以解决当前蛇咬伤治疗的缺陷
  • 批准号:
    MR/S03398X/2
  • 财政年份:
    2024
  • 资助金额:
    $ 132.05万
  • 项目类别:
    Fellowship
Re-thinking drug nanocrystals as highly loaded vectors to address key unmet therapeutic challenges
重新思考药物纳米晶体作为高负载载体以解决关键的未满足的治疗挑战
  • 批准号:
    EP/Y001486/1
  • 财政年份:
    2024
  • 资助金额:
    $ 132.05万
  • 项目类别:
    Research Grant
CAREER: FEAST (Food Ecosystems And circularity for Sustainable Transformation) framework to address Hidden Hunger
职业:FEAST(食品生态系统和可持续转型循环)框架解决隐性饥饿
  • 批准号:
    2338423
  • 财政年份:
    2024
  • 资助金额:
    $ 132.05万
  • 项目类别:
    Continuing Grant
Metrology to address ion suppression in multimodal mass spectrometry imaging with application in oncology
计量学解决多模态质谱成像中的离子抑制问题及其在肿瘤学中的应用
  • 批准号:
    MR/X03657X/1
  • 财政年份:
    2024
  • 资助金额:
    $ 132.05万
  • 项目类别:
    Fellowship
CRII: SHF: A Novel Address Translation Architecture for Virtualized Clouds
CRII:SHF:一种用于虚拟化云的新型地址转换架构
  • 批准号:
    2348066
  • 财政年份:
    2024
  • 资助金额:
    $ 132.05万
  • 项目类别:
    Standard Grant
The Abundance Project: Enhancing Cultural & Green Inclusion in Social Prescribing in Southwest London to Address Ethnic Inequalities in Mental Health
丰富项目:增强文化
  • 批准号:
    AH/Z505481/1
  • 财政年份:
    2024
  • 资助金额:
    $ 132.05万
  • 项目类别:
    Research Grant
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 132.05万
  • 项目类别:
    EU-Funded
BIORETS: Convergence Research Experiences for Teachers in Synthetic and Systems Biology to Address Challenges in Food, Health, Energy, and Environment
BIORETS:合成和系统生物学教师的融合研究经验,以应对食品、健康、能源和环境方面的挑战
  • 批准号:
    2341402
  • 财政年份:
    2024
  • 资助金额:
    $ 132.05万
  • 项目类别:
    Standard Grant
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 132.05万
  • 项目类别:
    EU-Funded
Recite: Building Research by Communities to Address Inequities through Expression
背诵:社区开展研究,通过表达解决不平等问题
  • 批准号:
    AH/Z505341/1
  • 财政年份:
    2024
  • 资助金额:
    $ 132.05万
  • 项目类别:
    Research Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了